Gofen & Glossberg LLC IL lowered its stake in CME Group Inc (NASDAQ:CME) by 43.1% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 3,813 shares of the financial services provider’s stock after selling 2,886 shares during the quarter. Gofen & Glossberg LLC IL’s holdings in CME Group were worth $517,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. ST Germain D J Co. Inc. purchased a new stake in CME Group during the third quarter worth about $232,000. Capital Advisors Inc. OK increased its stake in CME Group by 10.7% during the second quarter. Capital Advisors Inc. OK now owns 84,533 shares of the financial services provider’s stock worth $10,587,000 after purchasing an additional 8,198 shares during the period. Marvin & Palmer Associates Inc. increased its stake in CME Group by 100.7% during the second quarter. Marvin & Palmer Associates Inc. now owns 57,278 shares of the financial services provider’s stock worth $7,173,000 after purchasing an additional 28,745 shares during the period. Captrust Financial Advisors purchased a new stake in CME Group during the second quarter worth about $693,000. Finally, Commerce Bank increased its stake in CME Group by 3.8% during the second quarter. Commerce Bank now owns 560,899 shares of the financial services provider’s stock worth $70,247,000 after purchasing an additional 20,449 shares during the period. 83.17% of the stock is currently owned by institutional investors.

Shares of CME Group Inc (NASDAQ CME) opened at $150.42 on Friday. The company has a debt-to-equity ratio of 0.11, a quick ratio of 1.05 and a current ratio of 1.05. CME Group Inc has a one year low of $113.27 and a one year high of $155.29. The firm has a market cap of $51,413.22, a P/E ratio of 31.72, a P/E/G ratio of 3.11 and a beta of 0.73.

CME Group (NASDAQ:CME) last released its earnings results on Thursday, October 26th. The financial services provider reported $1.19 earnings per share for the quarter, topping the Zacks’ consensus estimate of $1.16 by $0.03. CME Group had a net margin of 40.94% and a return on equity of 7.89%. The firm had revenue of $890.80 million for the quarter, compared to analyst estimates of $890.22 million. During the same period in the prior year, the firm earned $1.05 earnings per share. The business’s quarterly revenue was up 5.8% compared to the same quarter last year. analysts predict that CME Group Inc will post 4.78 EPS for the current fiscal year.

The company also recently announced a None dividend, which will be paid on Monday, January 15th. Investors of record on Thursday, December 28th will be paid a dividend of $3.50 per share. The ex-dividend date is Wednesday, December 27th. CME Group’s payout ratio is 59.86%.

CME has been the topic of a number of recent research reports. Barclays initiated coverage on shares of CME Group in a research note on Friday, September 8th. They set an “overweight” rating and a $139.00 price target on the stock. BidaskClub lowered shares of CME Group from a “buy” rating to a “hold” rating in a research note on Friday, September 1st. UBS reiterated a “buy” rating and set a $135.00 price target (up from $134.00) on shares of CME Group in a research note on Wednesday, September 6th. Citigroup boosted their price target on shares of CME Group from $138.00 to $155.00 and gave the stock a “buy” rating in a research note on Thursday, October 19th. Finally, Wells Fargo & Company boosted their price target on shares of CME Group from $130.00 to $145.00 and gave the stock a “market perform” rating in a research note on Wednesday, October 4th. One equities research analyst has rated the stock with a sell rating, three have given a hold rating and eight have given a buy rating to the stock. The company currently has a consensus rating of “Buy” and an average price target of $141.75.

In related news, insider Julie Winkler sold 2,457 shares of the company’s stock in a transaction that occurred on Thursday, December 7th. The shares were sold at an average price of $150.41, for a total transaction of $369,557.37. Following the sale, the insider now directly owns 16,318 shares in the company, valued at $2,454,390.38. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, COO Julie Holzrichter sold 12,920 shares of the company’s stock in a transaction that occurred on Tuesday, November 28th. The shares were sold at an average price of $144.08, for a total value of $1,861,513.60. The disclosure for this sale can be found here. Insiders have sold 36,628 shares of company stock worth $5,288,800 over the last 90 days. Insiders own 0.57% of the company’s stock.

ILLEGAL ACTIVITY NOTICE: “CME Group Inc (CME) Holdings Reduced by Gofen & Glossberg LLC IL” was first reported by Watch List News and is the property of of Watch List News. If you are accessing this piece of content on another site, it was illegally stolen and reposted in violation of United States & international trademark & copyright legislation. The original version of this piece of content can be read at https://www.watchlistnews.com/cme-group-inc-cme-holdings-reduced-by-gofen-glossberg-llc-il/1764992.html.

CME Group Profile

CME Group Inc, through its exchanges, provides products across all asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The Company’s segment primarily consists of the Chicago Mercantile Exchange Inc (CME), Board of Trade of the City of Chicago, Inc (CBOT), New York Mercantile Exchange, Inc (NYMEX) and Commodity Exchange, Inc (COMEX) exchanges.

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.